NCT06099769 2026-02-25
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
Clinical Trials
18 trialsNCT03225547 2025-12-23
Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer
University of Chicago
Phase 2 Terminated
NCT02788981 2025-06-10
Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer
University of Chicago
Phase 2 Active not recruiting
NCT04254627 2025-02-19
E/M
Nova Southeastern University
Phase 1 Active not recruiting
NCT00133705 2023-09-25
Trial of Mifepristone for Fibroids
University of Rochester
Phase 3 Completed
NCT02012296 2022-07-13
Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer
University of Chicago
Phase 1/2 Completed
NCT02651844 2022-05-06
MIPRA
Hospital Provincial Magdalena V. de MartÃnez
Phase NA Completed
NCT01898312 2022-01-19
BRCA1/2 and Effect of Mifepristone on the Breast
Karolinska Institutet
Phase 2 Completed
NCT05016349 2021-08-23
Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.
Kafrelsheikh University
Phase 3 Unknown
NCT01138553 2019-07-08
Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast Cancer
University of California, San Diego
Phase EARLY_PHASE1 Terminated
NCT01493310 2018-09-12
Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer
University of Chicago
Phase 1 Completed
NCT02046421 2018-09-11
Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
University of Chicago
Phase 1 Completed
NCT00832871 2018-06-29
Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers
New Mexico Cancer Research Alliance
Phase NA Terminated
NCT00219778 2016-04-06
A Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine Leiomyomas
Poitiers University Hospital
Phase 2 Terminated
NCT00579475 2015-05-25
The Effect of Mifepristone on Uterine Fibroids and Breast Tissue
Karolinska Institutet
Phase 1 Completed
NCT00886873 2014-10-17
Mifemyo_2
Mediterranea Medica S. L.
Phase 2/3 Completed
NCT00140478 2009-12-09
Mifepristone (RU-486) in Androgen Independent Prostate Cancer
Dana-Farber Cancer Institute
Phase 2 Completed
NCT00712595 2009-04-23
Mifemyo
Mediterranea Medica S. L.
Phase 2/3 Completed